When did Neuropace, Inc. report Q4 2024 earnings?

Neuropace, Inc. (NPCE) reported Q4 2024 earnings on March 4, 2025 after market close.

What were Neuropace, Inc.'s Q4 2024 revenue and EPS?

Neuropace, Inc. reported revenue of $21.5M and diluted EPS of $-0.18 for Q4 2024.

Did Neuropace, Inc. beat estimates in Q4 2024?

Revenue missed the consensus estimate of $21.6M by $93.9K. EPS beat the consensus estimate of $-0.25 by $0.07.

Where can I find Neuropace, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0001528287-25-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.

Neuropace, Inc. NPCE Q4 2024 Annual earnings

Reported March 4, 2025 · After market close

Revenue$21.5MMiss by $93.9K Diluted EPS-$0.18Beat by $0.07

Revenue estimate$21.6M

EPS estimate-$0.25

Next report

Aug 11, 2026 (In 4 weeks)

Revenue estimate$22.6M

EPS estimate-$0.19

Financials

Q4 2024

Income statement

See full

Revenue$21.5M+19.2%

Gross profit$16.2M+19.5%

Operating income-$3.7M+27.7%

Net income-$5.3M+15.3%

EPS (diluted)-$0.17+22.7%

Balance sheet

See full

Cash & equivalents$13.6M-25.5%

Total debt$73.3M+1.3%

Total equity$8.0M-61.2%

Total assets$94.6M-12.1%

Cash flow

See full

Operating cash flow-$4.8M-43.6%

CapEx$39.0K+21.9%

Free cash flow-$4.8M-43.4%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$334M+20.9%

Enterprise value$393.79M+19.1%

P/S4.2×0.0×

Profitability

See full

Gross margin73.9%+0.4pp

Operating margin-27.1%-7.0pp

Net margin-34%-8.3pp

FCF margin-22.8%-4.5pp

Returns & leverage

See full

Return on equity-189.4%+275pp

Debt / equity9.2×+5.6×

Current ratio5.4×-0.3×

Versus estimates

Revenue

Q1 2026$22.0MBeat by $355.4K Q4 2025$26.6MBeat by $1.8M Q3 2025$27.4MBeat by $2.3M Q2 2025$23.5MMiss by $913.1K Q1 2025$22.5MMiss by $186.3K

Q4 2024$21.5MMiss by $93.9K

Diluted EPS

Q1 2026-$0.13Beat by $0.06 Q4 2025-$0.08Beat by $0.06 Q3 2025-$0.11Beat by $0.09 Q2 2025-$0.26Miss by $0.02 Q1 2025-$0.21Beat by $0.05

Q4 2024-$0.18Beat by $0.07

Ask the moment Neuropace, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Neuropace, Inc. report Q4 2024 earnings?: Neuropace, Inc. (NPCE) reported Q4 2024 earnings on March 4, 2025 after market close.
What were Neuropace, Inc.'s Q4 2024 revenue and EPS?: Neuropace, Inc. reported revenue of $21.5M and diluted EPS of $-0.18 for Q4 2024.
Did Neuropace, Inc. beat estimates in Q4 2024?: Revenue missed the consensus estimate of $21.6M by $93.9K. EPS beat the consensus estimate of $-0.25 by $0.07.
Where can I find Neuropace, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0001528287-25-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.